CN1136436A - Tablet for clearing head for cerebrorascular disease - Google Patents

Tablet for clearing head for cerebrorascular disease Download PDF

Info

Publication number
CN1136436A
CN1136436A CN96116211A CN96116211A CN1136436A CN 1136436 A CN1136436 A CN 1136436A CN 96116211 A CN96116211 A CN 96116211A CN 96116211 A CN96116211 A CN 96116211A CN 1136436 A CN1136436 A CN 1136436A
Authority
CN
China
Prior art keywords
tablet
vitamin
cerebrorascular
disease
clearing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN96116211A
Other languages
Chinese (zh)
Other versions
CN1061536C (en
Inventor
包仕尧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96116211A priority Critical patent/CN1061536C/en
Publication of CN1136436A publication Critical patent/CN1136436A/en
Application granted granted Critical
Publication of CN1061536C publication Critical patent/CN1061536C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention discloses a kind of medicine for anticerebrovascular diseases. It is mainly composed of pyra-thio-alcohol, valium, VB1, VB6, chondroitin sulfate, sodium glycerophosphate, and lysine for curing senile dementia, sequel of cerebro trauma, dizzy headache after encephalitis and meningitis, vertigo, insomnia, amnesia, diverting attention and morale variation etc..

Description

Clearing brain tablet
The present invention relates to the sick new drug of a kind of resisting cerebrovascular.
The various mental disorders that dementia that cerebral hypoplasia, brain atrophy cause and cerebrovascular ischemia cause, it is one of common encephalopathy of old people and child, the lighter can cause symptoms such as neurasthenia, hypomnesis, insomnia, lassitude, weight person can make patient's loss of consciousness, can't take care of oneself, make patient and family members all very painful.
The objective of the invention is: provide a kind of resisting cerebrovascular sick new drug--clearing brain tablet, it is for the alzheimer disease psychosis, cerebral trauma sequela, distending pain in the head behind encephalitis and the meningitis, dizzy insomnia, hypomnesis, absent minded, the improvement of emotion changes symptom and climacteric syndrome etc. all have special effect.
Technical scheme of the present invention is:
A kind of clearing brain tablet, its prescription comprises following component:
A. pyritinol 18--22;
B. stable 1.2--1.3;
C. vitamin B1 4.5--5.5;
D. vitamin B6 4.5--5.5;
E. Margarita powder 45--55;
F. chondroitin sulfate 27--33;
G. sodium glycerophosphate 27--33;
H. lysine 90--110.
Also contain proper quantity of medicinal auxiliary material in the described prescription, be beneficial to make tablet; Described pharmaceutic adjuvant is starch and dolomol.
Advantage of the present invention is:
1. can promote glucose and amino acid metabolism in the brain, improve the whole body assimilation, increase the carotid artery flow amount, improve cerebral blood flow, improve the cerebral biological electricity activity, finally make brain function obtain taking a turn for the better.
2. the aminoacid that has human body necessity--lysine, it can see through blood brain barrier and enter cerebral tissue, helps the neurocyte reparation, promotes the physiological function of nervous cell regenerating and anti-cerebral hypoxia, memory reinforcing.
3. have calmness, spasmolytic, analgesic activity, can be used for nervous migraine.
4. can obviously improve ischemia and give birth to tissue blood flow, improve cerebral infarction patient motion function and recover.
The invention will be further described below in conjunction with embodiment:
Embodiment: a kind of clearing brain tablet, adopt following prescription:
A. pyritinol 20;
B. stabilize 1.25;
C. vitamin B1 5;
D. vitamin B6 5;
E. Margarita powder 50;
F. chondroitin sulfate 30;
G. sodium glycerophosphate 30;
H. lysine 100.
Adopt following technology: powder such as pyritinol, stable, vitamin B1, vitamin B6, chondroitin sulfate, sodium glycerophosphate lysine are crossed 100 mesh sieves, add starch slurry 10%, mixed and stirred the back and cross 60 mesh sieves, 60 ℃ of oven dry, add an amount of hard acid magnesium powder, tabletting, sugar coating.
The present invention is for the alzheimer disease psychosis, cerebral trauma sequela, and the distending pain in the head behind encephalitis and the meningitis, dizzy insomnia, hypomnesis, absent minded, the improvement of emotion changes symptom and climacteric syndrome etc. all have special effect.

Claims (3)

1. clearing brain tablet, its prescription comprises following component:
A. pyritinol 18--22;
B. stable 1.2--1.3;
C. vitamin B1 4.5--5.5;
D. vitamin B6 4.5--5.5;
E. Margarita powder 45--55;
F. chondroitin sulfate 27--33;
G. sodium glycerophosphate 27--33;
H. lysine 90--110.
2. clearing brain tablet according to claim 1 is characterized in that: also contain proper quantity of medicinal auxiliary material in the described prescription, be beneficial to make tablet.
3. clearing brain tablet according to claim 2 is characterized in that: described pharmaceutic adjuvant is starch and dolomol.
CN96116211A 1996-01-09 1996-01-09 Tablet for clearing head for cerebrorascular disease Expired - Fee Related CN1061536C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96116211A CN1061536C (en) 1996-01-09 1996-01-09 Tablet for clearing head for cerebrorascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96116211A CN1061536C (en) 1996-01-09 1996-01-09 Tablet for clearing head for cerebrorascular disease

Publications (2)

Publication Number Publication Date
CN1136436A true CN1136436A (en) 1996-11-27
CN1061536C CN1061536C (en) 2001-02-07

Family

ID=5123333

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96116211A Expired - Fee Related CN1061536C (en) 1996-01-09 1996-01-09 Tablet for clearing head for cerebrorascular disease

Country Status (1)

Country Link
CN (1) CN1061536C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105520991A (en) * 2015-12-09 2016-04-27 贵州神奇药物研究院 Health product capable of preventing senile dementia and preparation method for health product
CN108936669A (en) * 2018-09-25 2018-12-07 泓博元生命科技(深圳)有限公司 Improve the composition and the preparation method and application thereof of memory
CN109170891A (en) * 2018-09-25 2019-01-11 泓博元生命科技(深圳)有限公司 A kind of composition and the preparation method and application thereof improving memory

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105520991A (en) * 2015-12-09 2016-04-27 贵州神奇药物研究院 Health product capable of preventing senile dementia and preparation method for health product
CN108936669A (en) * 2018-09-25 2018-12-07 泓博元生命科技(深圳)有限公司 Improve the composition and the preparation method and application thereof of memory
CN109170891A (en) * 2018-09-25 2019-01-11 泓博元生命科技(深圳)有限公司 A kind of composition and the preparation method and application thereof improving memory

Also Published As

Publication number Publication date
CN1061536C (en) 2001-02-07

Similar Documents

Publication Publication Date Title
JP2000514437A (en) Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine to increase IGF-1 levels
CN1061536C (en) Tablet for clearing head for cerebrorascular disease
CN103649106B (en) Be used for the treatment of compound and the pharmaceutical composition of nervus retrogression and ischemic cerebral disease
CN103372135A (en) Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance
CN101455359A (en) Oral preparation capable of promoting blood, reducing fat and protecting and strengthening health and preparation method thereof
CN101032599B (en) Healthy solution for conditioning skin and losing weight
CN112957413A (en) Traditional Chinese medicine composition for regulating and treating insomnia and preparation method
CN102283940B (en) Chinese medicinal preparation for treating palpitation
CN1048408C (en) Medicine for curing nervous system injury and angionosis
CN102228618B (en) Chinese medicinal powder for treating ischemic heart disease
CN1234393C (en) Chinese patent drug for treating primary hypopiesi
CN111658917A (en) Health care device for heart and brain health, reducing blood pressure and tonifying primordial qi of human body
CN1240654A (en) Compound gingko-red sage tablet and its preparing process
CN1057672C (en) Styracol tablet
CN1326549C (en) Chinese medicine for treating blood vessel nature feeble-mindedness
CN1114425C (en) Chinese patent medicine for treating coronary heart disease and hypertension
CN101559139A (en) Prescription of pure traditional Chinese medicine preparation for preventing and curing neurasthenia insomnia and preparation method thereof
CN1320905C (en) Inflammation-resisting pain-stopping preparation
CN114306548B (en) Traditional Chinese medicine composition for treating insomnia and application thereof
CN2595397Y (en) Pressure reducing cup
EP3622964B1 (en) Agent for the treatment of skin wounds or burns
CN1256142C (en) Chinese medicine for treating side reaction caused by insanity resisting medicine and its preparation method
CN1062461C (en) Senility-proof health medicine
CN1879760A (en) Compound medicine for treating high paralysis, fracture sequelae, cardiac infarction and splenomegaly
CN1231230C (en) Apoplexy treating capsule and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee